Comparison between Jaypee Infratech IPO and Parabolic Drugs IPO.
Jaypee Infratech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Parabolic Drugs IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Jaypee Infratech IPO is up to ₹2,257.61 Cr whereas the issue size of the Parabolic Drugs IPO is up to ₹200.00 Cr. The final issue price of Jaypee Infratech IPO is ₹102.00 per share and of Parabolic Drugs IPO is ₹75.00 per share.
| Jaypee Infratech IPO | Parabolic Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹102.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹117.00 per share | ₹85.00 per share |
| Issue Price (Final) | ₹102.00 per share | ₹75.00 per share |
| Discount (Retail) | ₹5.10 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 50 shares | 80 shares |
| Fresh Issue Size | 16,29,33,497 shares | 2,46,40,965 shares |
| Fresh Issue Size (Amount) | up to ₹1,650.00 Cr | up to ₹184.81 Cr |
| OFS Issue Size | 6,00,00,000 shares | 20,25,702 shares |
| OFS Issue Size (Amount) | up to ₹607.61 Cr | up to ₹15.19 Cr |
| Issue Size Total | 22,29,33,497 shares | 2,66,66,667 shares |
| Issue Size Total (Amount) | up to ₹2,257.61 Cr | up to ₹200.00 Cr |
Jaypee Infratech IPO opens on Apr 29, 2010, while Parabolic Drugs IPO opens on Jun 14, 2010. The closing date of Jaypee Infratech IPO and Parabolic Drugs IPO is May 04, 2010, and Jun 17, 2010, respectively.
| Jaypee Infratech IPO | Parabolic Drugs IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 29, 2010 | Jun 14, 2010 |
| Issue Close | May 04, 2010 | Jun 17, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | May 21, 2010 | Jul 01, 2010 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Jaypee Infratech IPO P/E ratio is , as compared to Parabolic Drugs IPO P/E ratio of .
| Jaypee Infratech IPO | Parabolic Drugs IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.1 | 63.21 | ||||
| Promoter Shareholding (Post-Issue) | 83.05 | 38.04 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹14186.15 Cr. | ₹464.19 Cr. | ||||
| ROE | ||||||
| ROCE | 6.21 | |||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 21.42 | 19.96 |
In the Jaypee Infratech IPO Retail Individual Investors (RII) are offered 6,06,95,864 shares while in Parabolic Drugs IPO retail investors are offered 6,06,95,864 shares. Qualified Institutional Buyers (QIB) are offered 12,13,91,729 shares in Jaypee Infratech IPO and 1,30,83,333 shares in Parabolic Drugs IPO.
| Jaypee Infratech IPO | Parabolic Drugs IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 0 shares | |
| QIB | 12,13,91,729 shares | 1,30,83,333 shares |
| NII | 2,02,31,954 shares | 39,25,000 shares |
| RII | 6,06,95,864 shares | 91,58,334 shares |
| Employee | 0 shares | 5,00,000 shares |
| Others | ||
| Total | 22,47,99,496 shares | 2,66,66,667 shares |
Jaypee Infratech IPO subscribed 1.22x in total, whereas Parabolic Drugs IPO subscribed 1.04x.
| Jaypee Infratech IPO | Parabolic Drugs IPO | |
|---|---|---|
| QIB (times) | 1.75x | 1.48x |
| NII (times) | 1.14x | 1.20x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.60x | 0.40x |
| Employee (times) | 0.11x | |
| Other (times) | ||
| Total (times) | 1.22x | 1.04x |
